Article

jdsupra.com on 2016-06-14 20:23

Update on Naming Biosimilars

JD Supra

Related news

Update on Biosimilars jdsupra.com
Samsung Bioepis Biosimilars Update jdsupra.com
Catalent Biosimilars Manufacturing Update jdsupra.com
Update on biosimilars - June 2018 jdsupra.com
California , United States , Switzerland
AbbVie Submits Citizen Petition on Interchangeable Biosimilars jdsupra.com
Biosimilars Update -- Pfizer's Proposed Epogen®/Procrit® Biosimilar Recommended for Approval jdsupra.com
Update on biosimilars in Canada – June 2022 jdsupra.com
Saskatchewan , Ontario , Quebec , New Brunswick , Alberta
Update on biosimilars in Canada – October 2019 jdsupra.com
California , United States , Switzerland , Canada
Update on biosimilars in Canada – March 2024 jdsupra.com
Newfoundland and Labrador , Ontario , Saskatchewan , Nova Scotia , New Brunswick
Update on biosimilars in Canada - October 2021 jdsupra.com
Ontario , New Brunswick , Alberta , British Columbia , Quebec
Update on biosimilars in Canada - April 2021 jdsupra.com
Canada
Update on biosimilars in Canada – March 2023 jdsupra.com
Nova Scotia , New Brunswick , Quebec , Northwest Territories , Alberta
Summary of Guidance on Interchangeability of Biosimilars With Reference Products jdsupra.com
EMA Releases Informational Guide on Biosimilars for Healthcare Providers jdsupra.com
FDA Issues In Final Guidance On Interchangeable Biosimilars jdsupra.com
California , United States , Switzerland
ASCO Issues Statement on Use of Biosimilars in Oncology jdsupra.com
Federal Circuit Backs Amgen on Key Provision of Biosimilars Statute jdsupra.com
HHS Announces Availability Of Draft Guidance On Therapeutic Protein Biosimilars jdsupra.com
California , United States , Switzerland
FDLI Conference On Drug, Biologics, And Biosimilars Law And Regulation jdsupra.com
California , United States , Switzerland
Update on FDA’s Approach to Labeling Biosimilars Like Generics jdsupra.com
Capitol Hill